Open AccessDurvalumab Gets FDA Green Light for Treatment of Extensive-Stage SCLC
Author(s) -
Brandon May
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000681608.55492.72
Subject(s) - durvalumab , medicine , carboplatin , lung cancer , etoposide , chemotherapy , oncology , stage (stratigraphy) , cancer , cisplatin , immunotherapy , nivolumab , paleontology , biology